Home' Australian Pharmacist : Australian Pharmacist Sept 2013 Contents 16 Australian Pharmacist September 2013 I ©Pharmaceutical Society of Australia Ltd.
Passive smoke case win
An increasing number of Australian war
widows are expected to claim pensions
for husbands who died from passive
smoking in combat.
This follows a ruling that passive
smoking in combat constituted a
"war-caused death", despite taking place
Perth woman Lillian Oliver lost her
husband, Leslie Richard Oliver, in 1980
to ischaemic heart disease. She claimed
he contracted the disease after constant
exposure to cigarette smoke on board
HMAS Culgoa in Korean waters in 1953.
In 2010 the Department of Veterans'
Affairs (DVA) Repatriation Commission
refused her a widow's pension because
her husband's death, at 45, fell outside
the parameters of war-caused deaths.
Last year the Veterans' Review Board
upheld the decision but last month
the Administrative Appeals Tribunal
overturned it, saying Mr Oliver "was in an
atmosphere with a visible tobacco smoke
haze in enclosed spaces for several hours
per day throughout the whole of his
The Repatriation Commission "did not
dispute any of the facts necessary to
support the... hypothesis connecting the
veteran's death with the circumstances of
his operational service", the AAT added.
The AAT was told that constant exposure
to tobacco smoke in confined spaces was
listed since the 1990s as a possible cause
of ischaemic heart disease in relation to
claims for widows' pensions, provided the
exposure was less than five years before
the onset of illness.
Gardasil journey detailed at
The story behind the research and
development of Gardasil -- with all its
challenges, obstacles and ultimate
triumphs -- is one of the most fascinating
and inspiring sagas to be found in
Now delegates to PAC13 will be able to
hear Professor Ian Frazer present the Alan
Russell Oration during which he will talk
about the Gardasil Journey and the trials,
tribulations, sacrifices -- and ultimate
successes -- he experienced in his amazing
quest and ultimately successful search
cofounding a cervical cancer vaccine.
Professor Frazer persevered when all
the odds were against him and his
subsequent discovery has revolutionised
the battle against cervical cancer.
This will be a truly inspirational and
compelling presentation about a
modern-day medical battle.
Adding interest is the fact that Professor
Frazer is currently leading the charge
to develop vaccination technology to
prevent and treat genital herpes.
This work has reached has reached the
next step in clinical trials with the aim to
be a prevention and cure for the Herpes
Simplex Virus (HSV-2) and if successful,
could lead to effective vaccinations or
remedies for currently incurable viruses
like HIV-AIDS or hepatitis C.
Professor Frazer, whose address can
be heard on the afternoon of Friday,
11 October, is one of a wide range of
expert speakers at PAC13 which this year
has moved to Brisbane.
The theme for PAC13 is ONE profession,
ONE focus, ONE voice which will focus
on unity in the profession, in the delivery
of services and in the goal of better
These are the keys to the profession
growing in the future and remaining
viable and sustainable while continuing
to improve the health and wellbeing of
PAC13 will be held at the Brisbane
Convention Centre from 10-13 October
2013. To register, go to psa.org.au/pac
NPS MedicineWise programs
targeting quality use of medicines
in cardiovascular management
have improved prescribing and
cardiovascular disease management
in primary care, according to a
study published in the Medical
Journal of Australia last month.
The study conducted by Dr Svetla
Gadzhanova and Professor Elizabeth
Roughead from the University
of South Australia with Mr Mark
Bartlett, former Team Leader,
Impact and Outcome Evaluation,
NPS MedicineWise concluded that
NPS MedicineWise cardiovascular
interventions delivered between
2002 and 2009 were associated with
significant improvements in medicine
utilisation and diagnostic test use in
cardiovascular management. It found
quality use of medicines programs
like those implemented by NPS
MedicineWise have the potential to
improve Australia's medicines use and
ABS figures released last month show
Australia earns almost $4 billion a year
from exporting medicines. Medicines
Australia Chief Executive Dr Brendan
Shaw said that Australia earns more
money exporting medicines than
that is does from exporting cars, wine
or scientific instruments. However,
Australia's annual medicines exports
have fallen back to $3.9 billion in
2012-13 from their peak of $4.1 billion
in 2009-10. 'While there's been lots of
debate about Australian industries
and their future, we have a real
opportunity to make the Australian
medicines industry a key component
of preparing the Australian economy
for a post-mining boom future,'
Dr Shaw said.
Links Archive Australian Pharmacist August 2013 Australian Pharmacist Oct 2013 Navigation Previous Page Next Page